ATLANTA, July 20, 2011 /PRNewswire/ — CryoLife, Inc. (NYSE:
CRY), a leading tissue processing and medical device Company
focused on cardiac and vascular surgery, announced today
that 2011 second quarter financial results will be released
on Thursday, July 28, 2011. On that day, the Company will
hold a teleconference call and live webcast at 10:00 a.m. Eastern
Time to discuss the results, followed by a question and answer
session hosted by Steven G. Anderson, president and chief executive
officer of CryoLife, Inc.
To listen to the live teleconference, please dial 201-689-8261 a
few minutes prior to 10:00 a.m. A replay of the
teleconference will be available July 28 through August 4 and can
be accessed by calling (toll free) 877-660-6853 or 201-612-7415.
The account number for the replay is 244 and the conference
number is 376045.
The live webcast and replay can be accessed by going to the
Investor Relations section of the CryoLife web site at www.cryolife.com and selecting
the heading Webcasts & Presentations.
About CryoLife, Inc.Founded in 1984, CryoLife, Inc. is a
leader in the processing and distribution of implantable living
human tissues for use in cardiac and vascular surgeries throughout
the U.S. and Canada. CryoLife’s CryoValve® SG pulmonary heart
valve, processed using CryoLife’s proprietary SynerGraft®
technology, has FDA 510(k) clearance for the replacement of
diseased, damaged, malformed, or malfunctioning native or
prosthetic pulmonary valves. CryoLife’s CryoPatch® SG
pulmonary cardiac patch has FDA 510(k) clearance for the repair or
reconstruction of the right ventricular outflow tract (RVOT), which
is a surgery commonly performed in children with congenital heart
defects, such as Tetralogy of Fallot, Truncus Arteriosus, and
Pulmonary Atresia. CryoPatch SG